Keywords: Tekmira, Alnyla, Damages claim, Know-how

Tekmira sues Alnylam for misuse of trade secrets and confidential info

Article | 21 March 2011

Canadian developer of RNA interference (RNAi) therapeutics Tekmira Pharmaceuticals (Nasdaq: TKMR) has filed a complaint against USA-based Alnylam Pharmaceuticals (Nasdaq: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Alnylam Pharmaceuticals

Tekmira Pharmaceuticals

Go to company listing